Marken delivers worldwide solutions for life sciences
To remain a world leader in supply chain logistics for 35 years, it takes determination, experience, the right team, and continuous innovation, all of which Marken has no shortage.
By integrating depot and logistics services into solutions that extend the reach of clinical trials to even the most remote regions of the world, Marken has bridged the distance between the patient and the essential resources of life science companies.
“Over the last four years, we have continually remained ahead of our competition,” said Wes Wheeler, CEO of Marken, citing technology, investments and personalized services as the driving factors during a recent interview.
RELATED CONTENT: US drugstore industry consolidates as Walgreens Boots Alliance acquires Rite Aid
Having been in the business of operating facilities and companies for over 35 years, Wheeler knows more than just a thing or two about successfully running an organization. With GlaxoSmithKline and Exxon Mobile on his impressive resume, Wheeler was initially attracted to join Marken because of its positive reputation, global positioning and efforts for expansion.
These were also influencing factors for Ariette van Strien to join Marken, CCO, and Dan Bell, VP for Regulatory Compliance and Technical Affairs.
“The initial attraction was the potential, and the continued attraction is the success that we have,” said van Strien, whose primary responsibility is to drive Marken forward with the right clients.
RELATED CONTENT: InCarda Therapeutics raises $5M for heart treatment in latest round of financing
“Marken is the best company around for specialized logistics, and I wanted to work for the company at the top of the list and apply my own knowledge,” said Bell.
All three executives take pride in working for a specialized logistics and supply chain provider that is solely dedicated to pharma and the life sciences industry. Identifying themselves as a vital link to transport pharmaceuticals to patients, Marken as an organization plays an important role within the clinical research industry for supply chain services related to drug development and disease control.
With over 50,000 temperature-controlled shipments each month, and a staff of 600+ individuals across the globe, how does one company answer the needs of a global population while consistently advancing amidst a hyper-competitive market? CLICK HERE to continue reading this profile on Business Review USA.
- KPMG: The biggest challenges facing global CEOs in 2023Leadership & Strategy
- What will the C-suite of tomorrow look like?Leadership & Strategy
- All change as Kinaxis announces trio of C-suite appointmentsLeadership & Strategy
- 10 of the best speakers at Procurement & Supply Chain LIVELeadership & Strategy